| abstract |
The present invention generally concerns methods and compositions for treating an individual with cancer utilizing polypeptide mutants of TEL. In particular embodiments, TEL polypeptides or peptides are employed having mutations at one or more of phosphorylation, acetylation, glycosylation, ubiquitination, or sumoylation sites, for example. |